EUSA Pharma
Shirley Delung is a seasoned professional in the biopharmaceutical industry, currently serving as a Senior Key Account Manager for Rare Disease at UCB Biopharma S/A since June 2024. With a strong background in oncology and rare diseases, Shirley has held key positions including Key Account Manager at Recordati Rare Diseases North America, where responsibilities included promoting Sylvant for Idiopathic Multi-centric Castleman Disease. Previous roles include Oncology Sales Specialist at Ipsen, Hospital Account Specialist at Pfizer, and Regional Account Manager at Spectrum Pharmaceuticals, showcasing a robust track record in account management, sales strategy, and KOL development. Shirley's expertise spans various therapeutic areas, including hematology, rheumatology, and oncology, complemented by a BS in Communications from East Tennessee State University.
This person is not in any offices
EUSA Pharma
1 followers
We are committed to transforming the lives of people affected by cancer or rare disease, globally. We continuously strive to uncover opportunities which address gaps across adult and paediatric care. Helping the people with few or no options available is at the heart of everything we do. EUSA Pharma is part of Recordati Rare Diseases (recordatirarediseases.com), the business unit dedicated to rare disease in the Recordati group. Recordati has a total staff of more than 4,300, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. More information can be found in the press release: https://www.recordati.com/resources/Pubblicazione/___58a6bc05f57c4861aae203c930cd1682_/eusa-closing-pr.pdf We see a need. We work together. We don’t give up.